Begin main content

New at CADTH — February 2017

Published on: February 13, 2017
Product Line: New at CADTH
Result type: Report

DRUG REIMBURSEMENT RECOMMENDATIONS

CADTH Common Drug Review       

HEALTH TECHNOLOGY MANAGEMENT PRODUCTS

Rapid Response

Reports completed in January 2017.

Recent summaries of evidence with critical appraisals include:

Horizon Scanning

Horizon Scan Roundup — 2016: Part 2

Issues in Emerging Health Technology

Issue 151: iFunny Channel Blockers: An Emerging Option for Heart Failure

CADTH Resources

In Brief:
Crushed Buprenorphine Tablets for Opioid Dependency

NEWS & EVENTS

Join us for the 2017 CADTH Symposium from April 23 to 25, 2017, in Ottawa, Ontario. This year’s theme is “Measuring Value in Theory and the Real World.” Registration is now open!

Read our February Evidence Matters column in Hospital News, “Diagnosing the flu on the fly: Point-of-care tests for influenza.”

Ken Bond, CADTH Director, Patient Engagement, Ethics, and International Affairs, co-authored the article, “Quality Assessment of Ethics Analyses for Health Technology Assessment,” published in the International Journal of Technology Assessment in Health Care.

CADTH is presenting a Network Meta-Analysis Workshop in Ottawa from February 22 to 24, 2017, led by Dr. George Wells.

BEYOND CADTH

The Canadian Association of Provincial Cancer Agencies (CAPCA) is hosting roundtables to bring stakeholders together for an in-person discussion about the sustainability of cancer drug funding in Canada. The roundtables will take place in Vancouver, British Columbia, on February 27, 2017, and Toronto, Ontario, on March 2, 2017. If you’re interested in participating, please contact Keltie Gale at keltie.gale@santishealth.ca and she will follow up with additional details.

The 2017 Preventing Overdiagnosis conference, Towards Responsible Global Solutions, will be held in Quebec City, from August 17 to 19, 2017.

CSA Group (Canadian Standards Association) has two draft standards related to kidney dialysis ready for public review. To review the drafts and post comments, visit the CSA Group draft review site at the links provided below. Public review comments will be accepted until end of day February 16, 2017.

TELL US WHAT YOU THINK

We love hearing how our products and services are influencing health care policies, clinical practices, and patient outcomes. If you have a success story to share, please get in touch with your CADTH Liaison Officer.

CADTH E-Alerts: Subscribe to receive the latest CADTH news, reports, feedback opportunities, and events.